Satoshi Nishiwaki
Nagoya, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications
Optimizing post-transplant tyrosine kinase inhibitor maintenance in Philadelphia chromosome-positive acute lymphoblastic leukaemia: A risk-adapted framework.
Journal: British journal of haematology
Published: April 25, 2026
Absence of Pretransplant Peripheral Blasts Is a Favorable Factor in Allogeneic Stem Cell Transplantation for Advanced Acute Lymphoblastic Leukemia.
Journal: Transplantation and cellular therapy
Published: February 22, 2026
Donor age as a dual-risk factor for donor safety and recipient survival in allogeneic haematopoietic stem cell transplantation.
Journal: British journal of haematology
Published: February 05, 2026
Ethics in clinical research: for participant protection and higher-quality research
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: October 01, 2025
Indications for allogeneic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: August 06, 2025
Dasatinib is superior to imatinib in adult Ph + ALL: a propensity score-matched analysis of pooled JALSG trial data.
Journal: International journal of hematology
Published: June 06, 2025
Post-transplant TKIs for Ph+ ALL: practices to date and clinical significance.
Journal: International journal of hematology
Published: November 18, 2024
Machine learning evaluation of intensified conditioning on haematopoietic stem cell transplantation in adult acute lymphoblastic leukemia patients.
Journal: Communications medicine
Published: August 29, 2024
Utility of allogeneic stem cell transplantation for adult Ph+ALL with complete molecular remission.
Journal: American journal of hematology
Published: October 18, 2023
Last Updated: 09/26/2026